Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Santen

This page shows the latest Santen news and features for those working in and with pharma, biotech and healthcare.

EMA accepts Santen’s application for glaucoma treatment STN1013001

EMA accepts Santen’s application for glaucoma treatment STN1013001

The European Medicines Agency (EMA) has accepted Santen Pharmaceutical’s (Santen) marketing authorisation application (MAA) for use of STN1013001 (cationic emulsion of latanoprost 50μg/ml) for lowering of intraocular pressure (IOP) ... The patented

Latest news

More from news
Approximately 2 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    Ophthalmology. Ophthalmology is dominated by a small number of the same therapies marketed by different companies in different regions; Regeneron, Bayer and Santen all market Eylea, whereas Novartis and Roche market

  • Deal Watch table for May 2014 Deal Watch table for May 2014

    653. Merck &Co / Santen. Asset / product acquisition. 2. Ophthalmology products in Japan, Europe and Asia Pacific with sales of $400m.

  • Pharma deals during May 2014 Pharma deals during May 2014

    Not content with the Bayer deals, Merck &Co also divested its ophthalmic business (mainly Timolol) in Japan, Asia Pacific and Europe to its licensee Santen.

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    22. Tracon Pharmaceuticals/ Santen Pharmaceutical Co. Licence. Tracon's anti‐endoglin antibodies, including TRC105 for wet AMD (p2).

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Luis Iglesias heads Santen EMEA Luis Iglesias heads Santen EMEA

    His promotion sees him succeed Shigeo Taniuchi. Luis Iglesias has been promoted as Santen’s EMEA head, a move that sees him succeed Shigeo Taniuchi - who returns to Japan to become ... Iglesias initially joined Santen in 2017 as its senior vice

  • Paolo Casati named as general manager of Santen Italy Paolo Casati named as general manager of Santen Italy

    Has over 30 years of experience in the sector. Eye care specialist Santen Pharma has appointed Paolo Casati as general manager of its Italian subsidiary. ... I am very excited to join the team to establish Santen Italy as one of the major companies of

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...

Quick links